A modified model of T-cell differentiation based on mTOR activity and metabolism

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 78, Issue 1, 2013, Pages 125-130

  Powell, Jonathan D ^a   Heikamp, Emily B ^a   Pollizzi, Kristen N ^a   Waickman, Adam T ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ANTIGEN RECOGNITION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FATE; CELL METABOLISM; CELL MIGRATION; CELL SURVIVAL; CELL TYPE; EFFECTOR CELL; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; HUMAN; IMMUNOLOGICAL MEMORY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; T LYMPHOCYTE; UPREGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84904903517     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2013.78.020214     Document Type: Article

References (29)

1. Allen A, Zheng Y, Gardner L, Safford M, Horton MR, Powell JD. 2004. The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction. J Immunol 172: 4797-4803.
2. + regulatory T cells. Blood 105: 4743-4748.
3. Bretscher P, Cohn M. 1970. A theory of self-nonself discrimination. Science 169: 1042-1049.
4. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198:1875-1886.
5. Choi SW, Gerencser AA, Nicholls DG. 2009. Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: Spare respiratory capacity and stochastic mitochondrial failure. J Neurochem 109: 1179-1191.
6. Cobbold SP, Adams E, Farquhar CA, Nolan KF, Howie D, Lui KO, Fairchild PJ, Mellor AL, Ron D, Waldmann H. 2009. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc Natl Acad Sci 106: 12055-12060.
7. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, Worley PF, Kozma SC, Powell JD. 2009. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30: 832-844.
8. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, Xiao B, Worley PF, Powell JD. 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12: 295-303.
9. Fox CJ, Hammerman PS, Thompson CB. 2005. Fuel feeds function:Energy metabolism and the T-cell response. Nat Rev Immunol 5: 844-852.
10. Gottschalk RA, Corse E, Allison JP. 2010. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J Exp Med 207: 1701-1711.
11. Janeway CA Jr. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 54: 1-13.
12. Jenkins MK. 1992. The role of cell division in the induction of clonal anergy. Immunol Today 13: 69-73.
13. Jenkins MK, Chen CA, Jung G, Mueller DL, Schwartz RH. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J Immunol 144: 16-22.
14. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10: 595-602.
15. Lafferty KJ, Cunningham AJ. 1975. A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci 53: 27-42.
16. Matzinger P. 2001. Essay 1: The Danger model in its historical context. Scand J Immunol 54: 4-9.
17. + T cells. Science 327: 1098-1102.
18. Pearce EL. 2010. Metabolism in T cell activation and differentiation. Curr Opin Immunol 22: 314-320.
19. Powell JD, Lerner CG, Schwartz RH. 1999. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. J Immunol 162: 2775-2784.
20. Powell JD, Pollizzi KN, Heikamp EB, Horton MR. 2012. Regulation of immune responses by mTOR. Annu Rev Immunol 30: 39-68.
21. Procaccini C, De Rosa V, Galgani M, Abanni L, Cali G, Porcellini A, Carbone F, Fontana S, Horvath TL, La Cava A, et al. 2010. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity 33: 929-941.
22. Schwartz RH. 1992. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065-1068.
23. Sengupta S, Peterson TR, Sabatini DM. 2010. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell 40: 310-322.
24. + T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant 11: 613-618.
25. Waickman AT, Powell JD. 2012. mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev 249: 43-58.
26. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. 2006. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 24: 677-688.
27. H2 responses. Nature 458: 351-356.
28. Zheng Y, Delgoffe GM, Meyer CF, Chan W, Powell JD. 2009b. Anergic T cells are metabolically anergic. J Immunol 183:6095-6101.
29. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35.